Related Experiment Video
Updated: Aug 31, 2025
08:16
Comparative Lesions Analysis Through a Targeted Sequencing Approach
Published on: November 5, 2019
6.8K
Synthesizing studies for comparing different treatment sequences in clinical trials.
Guoqing Diao1, Haijun Ma2, Donglin Zeng3
1Department of Biostatistics and Bioinformatics, Milken Institute School of Public Health, George Washington University, Washington, District of Columbia, USA.
Statistics in Medicine
|August 25, 2022
Summary
Optimizing cancer treatment sequences is crucial for patient survival. New methods estimate survival probabilities for sequential therapies, addressing data from separate trials and patient-specific factors.
Area of Science:
- Oncology
- Biostatistics
- Clinical Trials
Background:
- Cancer treatment advances improve patient survival, leading to multiple treatment lines.
- Sequential treatment data often comes from disparate clinical trials.
- Variability in treatment initiation periods and patient characteristics complicate treatment sequencing.
Purpose of the Study:
- To develop statistical methods for estimating overall survival probability for cancer treatment sequences.
- To enable comparison of different treatment sequences for optimizing patient outcomes.
- To address challenges in analyzing multi-line cancer treatment data.
Main Methods:
- Development of semiparametric methods within the potential outcome framework.
- Statistical procedures designed to handle data from separate clinical trials.
- Incorporation of patient-specific factors influencing treatment selection.
Main Results:
- Proposed methods allow estimation of survival probabilities for treatment sequences.
- The framework facilitates comparison of different sequential treatment strategies.
- Large sample properties of the inferential procedures are established.
Conclusions:
- The developed methods provide a robust approach to analyzing sequential cancer treatments.
- This research aids in optimizing long-term clinical outcomes for cancer patients.
- Application to colorectal cancer trials demonstrates practical utility.
Keywords:
Kolmogorov-Smirnov testbootstrap methoddata synthesizationselection biassemiparametric inferenceMore Related Videos
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
10.8K
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.4K
Related Concept Videos
01:16Clinical Trials
7.0K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
7.0K
01:16Crossover Experiments
2.9K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
2.9K
01:11Clinical Trials: Overview
3.3K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.3K
01:20Comparing the Survival Analysis of Two or More Groups
264
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
264
01:12Hazard Ratio
222
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
222
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
163
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
163